De Sanctis, V.; Soliman , A. .; Tzoulis, P. .; Daar , S. .; Kattamis, A. . .; Delaporta , P. .; Karimi , M. .; Yassin, M. A.; Zarei, T.; Saki, F.; Sapunarova, K.; Banchev, A.; Galati, M. C.; Raiola, G.; Messina, G.; Campisi , S. .; Kattamis, C. The Use of Oral Glucose-Lowering Agents (GLAs) in β-Thalassemia Patients With Diabetes: Preliminary Data from a Retrospective Study of ICET-A Network: Oral Glucose-Lowering Agents (GLAs) in β-Thalassemia Patients. Acta Biomed 2022, 93 (2), e2022162. https://doi.org/10.23750/abm.v93i2.12056.